Teva Pharmaceutical Industries Ltd. (TEVA) has experienced a significant uptick in bullish options activity, with a notable 21,139 call options traded. This represents four times the anticipated volume. The heightened trading activity is accompanied by an increase in implied volatility, which has risen nearly 4 points to 63.71%.
Among the most active options are the September 25 calls at strike prices of $14 and $18, together contributing almost 17,200 contracts to the total volume. The current Put/Call Ratio stands at a low 0.08, indicating a strong bullish sentiment among investors.
This surge in options trading activity comes ahead of Teva's scheduled earnings announcement on May 7th, suggesting that traders are positioning themselves in anticipation of potential positive developments.
